» Articles » PMID: 23744610

Protein Kinase A-dependent PSer(675) -β-catenin, a Novel Signaling Defect in a Mouse Model of Congenital Hepatic Fibrosis

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2013 Jun 8
PMID 23744610
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney disease (ARPKD). Cystic dysplasia of the intrahepatic bile ducts and progressive portal fibrosis characterize liver pathology in CHF/CD. At a cellular level, several functional morphological and signaling changes have been reported including increased levels of 3'-5'-cyclic adenosine monophosphate (cAMP). In this study we addressed the relationships between increased cAMP and β-catenin. In cholangiocytes isolated and cultured from Pkhd1(del4/del4) mice, stimulation of cAMP/PKA signaling (forskolin 10 μM) stimulated Ser(675) -phosphorylation of β-catenin, its nuclear localization, and its transcriptional activity (western blot and TOP flash assay, respectively) along with a down-regulation of E-cadherin expression (immunocytochemistry and western blot); these changes were inhibited by the PKA blocker, PKI (1 μM). The Rho-GTPase, Rac-1, was also significantly activated by cAMP in Pkhd1(del4/del4) cholangiocytes. Rac-1 inhibition blocked cAMP-dependent nuclear translocation and transcriptional activity of pSer(675) -β-catenin. Cell migration (Boyden chambers) was significantly higher in cholangiocytes obtained from Pkhd1(del4/del4) and was inhibited by: (1) PKI, (2) silencing β-catenin (siRNA), and (3) the Rac-1 inhibitor NSC 23766.

Conclusion: These data show that in fibrocystin-defective cholangiocytes, cAMP/PKA signaling stimulates pSer(675) -phosphorylation of β-catenin and Rac-1 activity. In the presence of activated Rac-1, pSer(675) -β-catenin is translocated to the nucleus, becomes transcriptionally active, and is responsible for increased motility of Pkhd1(del4/del4) cholangiocytes. β-Catenin-dependent changes in cell motility may be central to the pathogenesis of the disease and represent a potential therapeutic target.

Citing Articles

DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation.

Xiong Z, Yang L, Li N, Fu J, Liu P, Sun P Clin Transl Med. 2022; 12(12):e1133.

PMID: 36536485 PMC: 9763535. DOI: 10.1002/ctm2.1133.


Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.

Olaizola P, Rodrigues P, Caballero-Camino F, Izquierdo-Sanchez L, Aspichueta P, Bujanda L Nat Rev Gastroenterol Hepatol. 2022; 19(9):585-604.

PMID: 35562534 DOI: 10.1038/s41575-022-00617-7.


Phosphoproteomic Analysis Reveals Downstream PKA Effectors of AKAP Cypher/ZASP in the Pathogenesis of Dilated Cardiomyopathy.

Lv J, Pan Z, Chen J, Xu R, Wang D, Huang J Front Cardiovasc Med. 2021; 8:753072.

PMID: 34966794 PMC: 8710605. DOI: 10.3389/fcvm.2021.753072.


The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.

Liu J, Ren G, Li K, Liu Z, Wang Y, Chen T Cell Death Differ. 2021; 29(4):818-831.

PMID: 34799729 PMC: 8990017. DOI: 10.1038/s41418-021-00897-7.


A human multi-lineage hepatic organoid model for liver fibrosis.

Guan Y, Enejder A, Wang M, Fang Z, Cui L, Chen S Nat Commun. 2021; 12(1):6138.

PMID: 34686668 PMC: 8536785. DOI: 10.1038/s41467-021-26410-9.


References
1.
Happe H, Leonhard W, van der Wal A, van de Water B, Lantinga-van Leeuwen I, Breuning M . Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet. 2009; 18(14):2532-42. DOI: 10.1093/hmg/ddp190. View

2.
Strazzabosco M, Somlo S . Polycystic liver diseases: congenital disorders of cholangiocyte signaling. Gastroenterology. 2011; 140(7):1855-9, 1859.e1. PMC: 3109236. DOI: 10.1053/j.gastro.2011.04.030. View

3.
Taurin S, Sandbo N, Qin Y, Browning D, Dulin N . Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem. 2006; 281(15):9971-6. DOI: 10.1074/jbc.M508778200. View

4.
Kahlert U, Maciaczyk D, Doostkam S, Orr B, Simons B, Bogiel T . Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett. 2012; 325(1):42-53. DOI: 10.1016/j.canlet.2012.05.024. View

5.
Taurin S, Sandbo N, Yau D, Sethakorn N, Dulin N . Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am J Physiol Cell Physiol. 2008; 294(5):C1169-74. PMC: 3327159. DOI: 10.1152/ajpcell.00096.2008. View